PKD2 mutations tend to manifest in older individuals, presenting with milder symptoms, fewer kidney cysts, delayed hypertension onset, and less frequent end-stage renal disease than PKD1 mutations18,19. This evidence concerns the gene PKD1 and stage 5 chronic kidney disease.